Why is the rapid tumor marker testing market promising?
Growing Demand for Early Cancer Screening
Increased public health awareness and policy promotion have increased the demand for convenient and economical early cancer screening methods (such as FOB, PSA).
Auxiliary Diagnosis and Treatment Monitoring
Tumor marker testing can assist in cancer diagnosis, prognosis, monitoring treatment effects, and recurrence.
POCT and Primary Care Application Expansion
Rapid tests are suitable for non-central laboratory settings such as clinics and physical examination centers, expanding the market scope.
reOpenTest Tumor Marker Tests: Reliable, Convenient, Comprehensive
Covers Common Tumor Markers
Provides rapid tests for prostate cancer (PSA), colorectal cancer (FOB), liver cancer (AFP), broad-spectrum markers (CEA), etc.
Accurate and Reliable Results
Uses mature technology, performance is verified, and provides reliable test results.
Easy to Operate, Fast Results
Suitable for rapid screening and auxiliary diagnosis scenarios, no complex equipment required.
Help Distributors Grow Their Business
Provide a competitive new product line to help you enter or deepen the oncology diagnostics market.
Our Core Rapid Tumor Marker Test Products
Prostate Specific Antigen (PSA) Rapid Test
Used for preliminary screening of prostate cancer, convenient and fast.
View Details
Fecal Occult Blood (FOB) Rapid Test (Immunological Method)
Non-invasive detection of hidden blood in feces is an important means of large-scale screening for colorectal cancer (immunological method iFOB/FIT).
View Details
Alpha-Fetoprotein (AFP) Rapid Test
Mainly used for auxiliary diagnosis/monitoring and recurrence warning of primary liver cancer.
View Details
Carcinoembryonic Antigen (CEA) Rapid Test
Broad-spectrum tumor marker, can be used for auxiliary diagnosis, prognosis judgment and recurrence monitoring of various malignant tumors (such as colorectal cancer, lung cancer, gastric cancer, etc.).
View DetailsSeize the Tumor Detection Market and Expand Your Business Field
Tumor marker testing is an area with significant clinical significance and huge growth potential in the in vitro diagnostic market. By distributing reOpenTest's reliable and convenient rapid test reagents, you can effectively meet the needs of clinicians and physical examination institutions in early cancer screening, auxiliary diagnosis, and monitoring, thereby entering or deepening your business layout in the oncology diagnostic market and obtaining sustainable commercial returns. We will provide you with competitive products and professional support to help you succeed.
Ready to expand your tumor detection product line?
reOpenTest rapid tumor marker test reagents provide you with new growth opportunities. Contact us now for product information and cooperation plans.